GlassScriptPhysician profile
Heather D Blanchette
NPI 1316936347
$19,727.60
in general payments reported to CMS, 2019-2025
74 companies · $5,564 in 2025
The $5,564 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,756 · 2022: $2,242 · 2023: $4,057 · 2024: $6,108 · 2025: $5,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Long Term Medical Supply Or Device Loan: $2,098 · Education: $35.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,594.92 |
| Long Term Medical Supply Or Device Loan | $2,098.14 |
| Education | $35.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,012.63 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,874.18 | 2021-2025 | Enhertu, Lynparza, Imfinzi |
| Janssen Biotech, INC. | $997.51 | 2021-2025 | Rybrevant, Darzalex, Carvykti |
| Lilly USA, LLC | $840.25 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Incyte Corporation | $773.79 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Daiichi Sankyo INC. | $722.63 | 2022-2025 | Enhertu, Datroway |
| Genzyme Corporation | $706.68 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $687.55 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Rigel Pharmaceuticals, INC. | $582.00 | 2021-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Pfizer INC. | $578.41 | 2022-2025 | |
| Glaxosmithkline, LLC. | $573.74 | 2023-2025 | Ojjaara, Jemperli, Zejula |
| Celgene Corporation | $526.66 | 2023-2025 | Reblozyl |
| Ipsen Biopharmaceuticals, INC | $487.29 | 2021-2025 | Onivyde, Somatuline Depot |
| Abbvie INC. | $457.40 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $370.45 | 2022-2025 | Reblozyl, Opdivo, Augtyro |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $337.29 | 2021-2025 | Trodelvy |
| Karyopharm Therapeutics INC. | $326.42 | 2022-2025 | Xpovio |
| Takeda Pharmaceuticals U.S.A., INC. | $322.47 | 2023-2024 | Alunbrig, Fruzaqla, Ninlaro |
| Blueprint Medicines Corporation | $298.75 | 2022-2025 | Ayvakit |
| Bayer Healthcare Pharmaceuticals INC. | $254.46 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $250.01 | 2023-2025 | Libtayo |
| Eisai INC. | $238.43 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $236.44 | 2021-2025 | |
| Seagen INC. | $231.60 | 2021-2023 | Padcev, Tukysa |
| Pharmacyclics LLC, An Abbvie Company | $210.37 | 2021-2023 | Imbruvica |
| Myriad Genetic Laboratories, INC. | $193.82 | 2022-2025 | Myrisk |
| Kite Pharma, INC. | $177.67 | 2021-2024 | Yescarta |
| Array Biopharma INC | $168.51 | 2024-2025 | Braftovi, Mektovi, Lorbrena |
| Adaptive Biotechnologies Corporation | $158.64 | 2023-2024 | Clonoseq |
| Stryker Corporation | $149.01 | 2024 | Spinejack |
| Astellas Pharma US INC | $141.36 | 2021-2025 | Xtandi, Padcev |
| Csl Behring | $137.07 | 2021-2025 | Afstyla, Idelvion, Hemgenix |
| Aveo Pharmaceuticals, INC. | $133.20 | 2022-2025 | Fotivda |
| Astellas Pharma Global Development | $125.44 | 2023 | Padcev |
| Dendreon Pharmaceuticals LLC | $125.34 | 2024-2025 | Provenge |
| Pharmacosmos Therapeutics INC. | $125.15 | 2023-2025 | Monoferric, Cosela |
| Sanofi US Services INC. | $121.21 | 2025 | |
| Sobi, INC | $118.71 | 2023-2025 | |
| Exelixis INC. | $112.67 | 2022-2024 | Cabometyx |
| Amgen INC. | $108.43 | 2022 | |
| Alexion Pharmaceuticals, INC. | $95.19 | 2024-2025 | Ultomiris |
| Janssen Pharmaceuticals, INC | $93.79 | 2023-2024 | Xarelto |
| Cti Biopharma Corp. | $93.74 | 2022-2023 | Vonjo |
| Genentech USA, INC. | $89.49 | 2022-2023 | Perjeta, Phesgo, Kadcyla |
| Pharmaessentia USA Corporation | $87.89 | 2023-2025 | Besremi |
| Janssen Scientific Affairs, LLC | $84.43 | 2023 | Balversa |
| Kyowa Kirin, INC. | $80.75 | 2024-2025 | Poteligeo |
| Puma Biotechnology, INC. | $75.77 | 2022-2025 | Nerlynx |
| Stemline Therapeutics INC. | $74.77 | 2023-2025 | Orserdu |
| Morphosys, US INC. | $68.95 | 2022 | |
| Deciphera Pharmaceuticals INC. | $68.44 | 2021-2024 | Qinlock |
| Taiho Oncology, INC. | $66.91 | 2024-2025 | |
| Beigene USA, INC. | $66.63 | 2021-2024 | Brukinsa, Tevimbra |
| Emd Serono, INC. | $63.70 | 2023-2025 | Bavencio |
| Alnylam Pharmaceuticals INC. | $55.99 | 2023-2024 | Givlaari |
| Tersera Therapeutics LLC | $47.47 | 2023-2025 | Zoladex |
| Myovant Sciences INC. | $44.82 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.25 | 2021-2023 | Gilotrif |
| Syndax Pharmaceuticals, INC. | $41.21 | 2025 | |
| Servier Pharmaceuticals LLC | $40.54 | 2024 | |
| Tactile Systems Technology INC | $40.00 | 2022 | |
| Mirati Therapeutics, INC. | $39.89 | 2023-2024 | Krazati |
| Legend Biotech USA INC. | $39.08 | 2024-2025 | Carvykti |
| Adc Therapeutics America, INC. | $38.41 | 2022-2024 | |
| Agios Pharmaceuticals, INC. | $37.16 | 2023-2024 | Pyrukynd |
| Geron Corporation | $25.68 | 2025 | Rytelo |
| Iovance Biotherapeutics, INC. | $21.44 | 2025 | Amtagvi |
| Sun Pharmaceutical Industries INC. | $20.98 | 2022 | |
| Recordati_rare_diseases_inc. | $16.75 | 2025 | Enjaymo |
| Sumitomo Pharma America, INC. | $16.57 | 2025 | Orgovyx |
| G1 Therapeutics, INC. | $14.92 | 2022 | |
| Ge Healthcare | $13.85 | 2021 | |
| Acceleron Pharma, INC. | $12.85 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.65 | 2021 |
Drugs and devices associated with these payments
Kisqali $2,326Enhertu $826Reblozyl $697Keytruda $586Jakafi $446Ojjaara $379Rezlidhia $376Tavalisse $376Sarclisa $349Lynparza $344Rybrevant $342Ayvakit $315Padcev $304Imbruvica $296Tukysa $268Xpovio $254Libtayo $250Onivyde $249Darzalex $242Jaypirca $240Verzenio $240Imfinzi $233Epkinly $221Alunbrig $214Datroway $212Carvykti $210Jemperli $195Ibrance $193Zepzelca $181Myrisk $181Braftovi $169Clonoseq $159Zejula $159Nubeqa $153Spinejack $149Somatuline Depot $149Pluvicto $146Scemblix $146Opdivo $145Inlyta $142Balversa $137Tecvayli $137Provenge $125Retevmo $125Trodelvy $124Mektovi $121Xtandi $121Lorbrena $120Fotivda $120Gavreto $119Lenvima $114Talvey $110Xofigo $108Erleada $106Monoferric $104Monjuvi $101Cabometyx $101Lutathera $100Doptelet $99.39Yescarta $97.45Ultomiris $95.19Xarelto $93.79Tasigna $91.85Besremi $87.89Afstyla $85.44Idelvion $85.44Piqray $84.99Fabhalta $84.91Poteligeo $80.75Fruzaqla $76.06Welireg $74.97Orserdu $74.77Calquence $74.63Elrexfio $70.76Vitrakvi $69.66Stivarga $69.66Venclexta $69.58Bosulif $69.01Lonsurf $66.91Inqovi $66.91Promacta $64.27Nerlynx $59.03Adcetris $58.94Talzenna $58.69Comirnaty $58.10Givlaari $55.99Xalkori $50.20Zynyz $49.46Zoladex $47.47Enjaymo $47.20Kadcyla $46.55Perjeta $46.55Phesgo $46.55Wayrilz $39.91Krazati $39.89Bavencio $38.91Paxlovid $37.78Vonjo $36.60Besponsa $34.21Ninlaro $32.66
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Blanchette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.